Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2021-10-15
2023-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Asthma Breath Biomarker Assessment
NCT03084016
Evaluation of Novel Lung Function Parameters in Patients With Bronchial Asthma
NCT03820427
The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples
NCT01631162
Pathogenetic Mechanisms of Chronic Obstructive Pulmonary Diseases
NCT01378039
Bronchoscopy Study for Severe Asthma
NCT01745809
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Occupational Asthma
Patients refered for assesment of occupational asthma
Breath Biopsy
ReCIVA breath sampler (Owlstone Medical, Cambridge, UK)
Respiratory Healthy Control
Employees at Oslo University Hospital
Breath Biopsy
ReCIVA breath sampler (Owlstone Medical, Cambridge, UK)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breath Biopsy
ReCIVA breath sampler (Owlstone Medical, Cambridge, UK)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* asthma diagnosis established by lung specialist or healthy control.
Exclusion Criteria
* immunocompromised by oral medication.
* contagious respiratory disease.
* biopsy of lung parenchyma within the last 36 hours.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Owlstone Ltd
INDUSTRY
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bato Hammarstrøm
Senior consultant/Research group leader
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bato Hammarstrøm, MD/PhD
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Tonje Trulssen Hildre, M.Sc.
Role: STUDY_CHAIR
Oslo University Hospital
Hilde Heiro, MD
Role: STUDY_CHAIR
Oslo University Hospital
Britt G Randem, MD/PhD
Role: STUDY_CHAIR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UO1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.